Interpace Diagnostics Group's total assets for Q3 2024 were $14.04M, an increase of 8.23% from the previous quarter. IDXG total liabilities were $25.18M for the fiscal quarter, a -1.09% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.